Home >
FEATURED BLOGS
Think Globally, Act Locally
Linda R. Duska, MD, MPH
Sep 19, 2019
Imagine a world in which global oncology is studied as rigorously as hematology/oncology, palliative medicine, or public health. What might we accomplish?
Tumor Boards in the Era of Patient Engagement
Don S. Dizon, MD, FACP, FASCO
Sep 17, 2019
Dr. Kelly Shanahan and I discuss how to involve a patient in tumor board discussions. How does your institution handle this?
Breakthrough to the Future: Why ASCO Breakthrough Is the Meeting We’ve Been Waiting For
Miriam Knoll, MD
Sep 11, 2019
Bringing together research from all the world is the best way to advance medicine. Enter, ASCO Breakthrough.
Androgen Deprivation Therapy and Alzheimer’s Disease: Risk/Benefit
L. Michael Glode, MD, FACP, FASCO
Sep 09, 2019
A recent study on the risk of Alzheimer's disease or dementia following the use of ADT was disturbing to me on two levels.
“Nothing Can Be Done”: A Single Sentence That Took Away Hope
Anne Katz, PhD, RN, FAAN
Sep 09, 2019
An inaccurate prognosis given at an urgent care center destroyed my patient's hope. Little by little, I will try to help him rebuild it.
1 Comment
Best of ASCO Keeps Getting Better!
Nagi S. El Saghir, MD, FACP, FASCO
Aug 12, 2019
Over 400 attendees and exceptional international faculty members made the 2019 Best of ASCO Lebanon meeting a great success.
On Kindness and Gratitude: Reflections From the Other Side of Cancer
Women in Oncology
Aug 12, 2019
After a breast cancer diagnosis, cancer researcher Dr. Priscila Gonçalves went from "helper" to "helped." She discovered incredible kindness along the way.  

Advertisement

Latest Comments & Discussions

Discussion > Re: Lung- MET Gene Amplification (September 2019): Multidisciplinary Molecular Tumor Board

ASCO University
Sep 18, 2019
Key Takeaways on behalf of Ravi Salgia There can be several biomarkers that are relevant to MET biology and therapeutics MET...
Discussion > Re: Lung- MET Gene Amplification (September 2019): Multidisciplinary Molecular Tumor Board

ASCO University
Sep 18, 2019
Key Takeaways on behalf of Sanja Dacic MET amplification and MET exon 14 mutations have been recognized by current clinical...
Discussion > Re: Lung- MET Gene Amplification (September 2019): Multidisciplinary Molecular Tumor Board

ASCO University
Sep 18, 2019
Course Faculty Response on behalf of Ravi Salgia Crizotinib has an FDA breakthrough therapy designation for the treatment of patients...
Discussion > Re: Lung- MET Gene Amplification (September 2019): Multidisciplinary Molecular Tumor Board

ASCO University
Sep 18, 2019
Course Faculty Response on behalf of Sanja Dacic MET exon 14 alterations have been shown to occur in approximately 3% of lung...
Discussion > Re: Lung- MET Gene Amplification (September 2019): Multidisciplinary Molecular Tumor Board

ASCO University
Sep 18, 2019
Discussion Questions How does one detect MET exon 14 splice variants? What are the therapies available for this disease? How do...

Pages

Most Read

Blog
Best of ASCO Keeps Getting Better!
Over 400 attendees and exceptional international faculty members made the 2019 Best of ASCO Lebanon meeting a great success.
Blog
On Kindness and Gratitude: Reflections From the Other Side of Cancer
After a breast cancer diagnosis, cancer researcher Dr. Priscila Gonçalves went from "helper" to "helped." She discovered incredible kindness along the way.  
Blog
Real-World Evidence: Time for a Reality Check
Does big data have a big problem? Dr. John W. Sweetenham cautions, "There is a real danger that we legitimize flawed data sets by labelling them as 'real-world data' when they neither reflect the real world nor can we trust the data."
Blog
“Nothing Can Be Done”: A Single Sentence That Took Away Hope
An inaccurate prognosis given at an urgent care center destroyed my patient's hope. Little by little, I will try to help him rebuild it.
Blog
Oncologist, Dad, Social Media Proponent: How These Identities Shape a Worldview
Dr. Gil Morgan joins me in a conversation about how our perspectives have been enriched by work, parenthood, and online connections.

Tweets from ASCO

Tweets from Oncology Community